Clinical trial
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
NCT01490905 is registered in ClinicalTrials.gov with Targeted Medical Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
- Lead sponsor
- Targeted Medical Pharma
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2010
- Completion date
- April 30, 2011
- Enrollment
- 127 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic low back pain